Cerecor Inc. logo
Cerecor Inc. CERC

Cerecor Inc. Revenue 2011-2026 | CERC

Company revenue is the total amount of money received from the sale of goods or services over a certain period of time. It is one of the key indicators of a company's financial condition and success.

Traditionally defined as follows:
Revenue = Price * Quantity of products

Revenue is one of the components of a company’s income. In international practice, revenue is understood as the inflow or other increase in a company's assets or the settlement of its obligations that occurs as a result of the company’s core or main activity.[1]

This is an important indicator for assessing the financial condition and efficiency of a company. It makes it possible to determine how successfully a company sells its products or services on the market. In addition, revenue can be used to calculate other financial indicators such as profit, profitability, and market share.

Various factors can influence this indicator, including demand for goods or services, market competition, economic conditions, and the company's marketing efforts. Therefore, its analysis and monitoring are important tasks for the successful development of a business.

Annual Revenue Cerecor Inc.

2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
6.7 M 6.75 M 18.3 M 27.8 M 1.15 M - - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
27.8 M 1.15 M 12.1 M

References

  1. Adhikari, B. (2010). Impact of Revenue Planning In Nepal Investment Bank Limited (Doctoral dissertation, Faculty of Management).

Revenue of other stocks in the Biotechnology industry

Issuer Revenue Price % 24h Market Cap Country
Biohaven Pharmaceutical Holding Company Ltd. Biohaven Pharmaceutical Holding Company Ltd.
BHVN
463 M $ 9.33 1.41 % $ 603 M usaUSA
MorphoSys AG MorphoSys AG
MOR
238 M - 2.43 % $ 254 M germanyGermany
I-Mab I-Mab
IMAB
88 M - - $ 866 M chinaChina
Midatech Pharma plc Midatech Pharma plc
MTP
381 K - -18.52 % $ 27.3 M britainBritain
Alexion Pharmaceuticals, Inc. Alexion Pharmaceuticals, Inc.
ALXN
6.07 B - - $ 40.3 B usaUSA
Aptorum Group Limited Aptorum Group Limited
APM
912 K $ 0.87 -2.13 % $ 6.4 M chinaChina
Genfit SA Genfit SA
GNFT
70.9 M - 2.54 % $ 160 B franceFrance
ACADIA Pharmaceuticals ACADIA Pharmaceuticals
ACAD
958 M $ 22.38 0.81 % $ 3.71 B usaUSA
EyeGate Pharmaceuticals, Inc. EyeGate Pharmaceuticals, Inc.
EYEG
12.1 K - -1.52 % $ 24.7 M usaUSA
Galapagos NV Galapagos NV
GLPG
1.11 B $ 28.15 1.04 % $ 2.69 B belgiumBelgium
Advaxis Advaxis
ADXS
13 K - -9.65 % $ 45.9 M usaUSA
Grifols, S.A. Grifols, S.A.
GRFS
7.21 B $ 8.22 3.92 % $ 6.83 B spainSpain
Harmony Biosciences Holdings Harmony Biosciences Holdings
HRMY
868 M $ 30.95 -0.34 % $ 1.78 B usaUSA
Институт стволовых клеток человека Институт стволовых клеток человека
ISKJ
1.08 B - - - russiaRussia
ImmuCell Corporation ImmuCell Corporation
ICCC
27.6 M $ 8.43 -0.12 % $ 76.1 M usaUSA
InflaRx N.V. InflaRx N.V.
IFRX
29.3 K $ 1.97 -0.51 % $ 152 M germanyGermany
Incyte Corporation Incyte Corporation
INCY
5.14 B $ 98.55 -0.55 % $ 19.2 B usaUSA
InMed Pharmaceuticals InMed Pharmaceuticals
INM
4.14 M $ 0.71 1.27 % $ 1.74 M canadaCanada
Innoviva Innoviva
INVA
411 M $ 22.97 -0.35 % $ 1.55 B usaUSA
Aeterna Zentaris Aeterna Zentaris
AEZS
7.5 M - 5.93 % $ 314 M canadaCanada
AgeX Therapeutics AgeX Therapeutics
AGE
130 K - -10.17 % $ 12.2 K usaUSA
BioNTech SE BioNTech SE
BNTX
482 M $ 104.02 2.41 % $ 27.2 B germanyGermany
Aeglea BioTherapeutics Aeglea BioTherapeutics
AGLE
886 K - - $ 1.01 B usaUSA
Jaguar Health Jaguar Health
JAGX
11.5 M $ 7.34 -6.79 % $ 17.1 M usaUSA
Applied Genetic Technologies Corporation Applied Genetic Technologies Corporation
AGTC
325 K - - $ 26.5 M usaUSA
AIkido Pharma AIkido Pharma
AIKI
123 M - 1.93 % $ 17.4 M usaUSA
KalVista Pharmaceuticals KalVista Pharmaceuticals
KALV
49.1 M $ 26.68 0.02 % $ 1.44 B britainBritain
Innate Pharma S.A. Innate Pharma S.A.
IPHA
9 M $ 1.45 -2.68 % $ 235 M franceFrance
Kamada Ltd. Kamada Ltd.
KMDA
180 M $ 8.16 0.68 % $ 260 M israelIsrael
Krystal Biotech Krystal Biotech
KRYS
389 M $ 260.24 0.11 % $ 7.53 B usaUSA
Kazia Therapeutics Limited Kazia Therapeutics Limited
KZIA
1.07 M $ 13.58 9.34 % $ 1.8 B australiaAustralia
Ligand Pharmaceuticals Incorporated Ligand Pharmaceuticals Incorporated
LGND
167 M $ 220.06 -2.13 % $ 4.02 B usaUSA
AlloVir AlloVir
ALVR
165 K - 4.14 % $ 49.1 M usaUSA
Can-Fite BioPharma Ltd. Can-Fite BioPharma Ltd.
CANF
853 K $ 2.94 -1.67 % $ 4.84 M israelIsrael
Liquidia Corporation Liquidia Corporation
LQDA
158 M $ 38.41 0.67 % $ 3.31 B usaUSA
Ampio Pharmaceuticals Ampio Pharmaceuticals
AMPE
1.16 M - -11.43 % $ 502 K usaUSA
CureVac N.V. CureVac N.V.
CVAC
48.9 M - - $ 867 M germanyGermany
Applied Therapeutics Applied Therapeutics
APLT
9.99 M - - $ 8.42 M usaUSA
Aquestive Therapeutics Aquestive Therapeutics
AQST
44.5 M $ 4.08 0.62 % $ 436 M usaUSA
Aptinyx Aptinyx
APTX
1 M - -39.0 % $ 4.57 M usaUSA
Aravive Aravive
ARAV
9.14 M - -13.39 % $ 1.45 M usaUSA
Aridis Pharmaceuticals Aridis Pharmaceuticals
ARDS
3.09 M - 17.91 % $ 11.1 M usaUSA
Arcutis Biotherapeutics Arcutis Biotherapeutics
ARQT
376 M $ 23.15 3.49 % $ 2.95 B usaUSA